Crossmark

“If they take it without knowing, they will default…”: perceptions of targeted information transfer to promote adherence to intermittent preventive treatment with dihydroartemisinin-piperaquine for the prevention of malaria in pregnancy in western Kenya

Crossref DOI link: https://doi.org/10.1186/s12936-024-05131-6

Published Online: 2024-11-29

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hoyt, Jenna

Barsosio, Hellen C.

Odero, Isdorah A.

Omondi, Benson

Achieng, Florence

Kariuki, Simon

Hill, Jenny

Webster, Jayne
Funding

Funding for this research was provided by:

European & Developing Countries Clinical Trials Partnership EDCTP2 (TRIA-2015-1076-IMPROVE)

Joint Global Health Trials scheme (MR/P006922/1)

Swedish International Development Cooperation Agency
License Information

Text and Data Mining valid from 2024-11-29

Version of Record valid from 2024-11-29
More Information

Article History

Received: 16 January 2024

Accepted: 5 October 2024

First Online: 29 November 2024

Declarations

:

: The Kenya Medical Research Institute’s (KEMRI) Scientific and Ethics Review Unit (SERU) [CGHR/005/3751], Kenya, and the research ethics committees of the Liverpool School of Tropical Medicine [18–073], UK, the London School of Hygiene and Tropical Medicine [17179], UK and the University of Bergen [2018/2112], Norway approved the trial. The study team obtained written informed consent from participants before data collection.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below